The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®
Open accessAbstract
Invasive Scedosporium spp.and Lomentospora prolificans infections are an emerging threat in immunocompromised and occasionally in healthy hosts.Scedosporium spp. is intrinsically resistant to most, L. prolificans to all the antifungal drugs currently approved, raising concerns about appropriate treatment decisions.High mortality rates of up to 90% underline the need for comprehensive diagnostic workup and even more for new, effective antifungal drugs to improve patient outcome.For a comprehensive analysis, we identified cases of severe Scedosporium spp.and L. prolificans infections from the literature diagnosed in 2000 or later and the FungiScope V R registry.For 208 Scedosporium spp.infections solid organ transplantation (n ¼ 58, 27.9%) and for 56 L. prolificans infection underlying malignancy (n ¼ 28, 50.0%) were the most prevalent risk factors.L. prolificans infections frequently presented as fungemia (n ¼ 26, 46.4% versus n ¼ 12, 5.8% for Scedosporium spp.).Malignancy, fungemia, CNS and lung involvement predicted worse outcome for scedosporiosis and lomentosporiosis.Patients treated with voriconazole had a better overall outcome in both groups compared to treatment with amphotericin B formulations.This review discusses the epidemiology, prognostic factors, pathogen susceptibility to approved and investigational antifungals, and treatment strategies of severe infections caused by Scedosporium spp.and L. prolificans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917
Self-citationPatterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Self-citationF901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase
Oliver, J. D., Sibley, G. E. M., Beckmann, N., Dobb, K. S., Slater, M. J., McEntee, L., du Pré, S., Livermore, J., Bromley, M. J., Wiederhold, N. P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608304113 · Cited by 289
Castanheira, M., Duncanson, F. P., Diekema, D. J., Guarro, J., Jones, R. N., & Pfaller, M. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05414-11 · Cited by 98 · cited 2×
“…APX001 (E1210) a novel antifungal agent that disrupts fungal cell wall assembly, showed good in vitro activity against Scedosporium spp. and L. prolificans and is currently tested in phase I clinical trial in patients with acute leukaemia (clinicaltrials.gov 2017; Castanheira et al. 2012).”
Background
Cited by
Hoenigl, M., Salmanton-García, J., Walsh, T. J., Nucci, M., Neoh, C. F., Jenks, J. D., Lackner, M., Sprute, R., Al-Hatmi, A. M. S., Bassetti, M., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30784-2 · Cited by 470
Self-citationEmerging Fungal Infections: New Patients, New Patterns, and New Pathogens
Friedman, D. Z. P., & Schwartz, I. S. (2019) · Journal of Fungi · doi:10.3390/jof5030067 · Cited by 357
Race and ethnicity: Risk factors for fungal infections?
Jenks, J. D., Aneke, C. I., Al-Obaidi, M. M., Egger, M., Garcia, L., Gaines, T., Hoenigl, M., & Thompson, G. R. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011025 · Cited by 55
Spallone, A., & Schwartz, I. S. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.014 · Cited by 48
Metadata
- Authors
- Seidel, D., Meißner, A., Lackner, M., Piepenbrock, E., Salmanton-García, J., Stecher, M., Mellinghoff, S., Hamprecht, A., Durán Graeff, L., Köhler, P., Cheng, M. P., Denis, J., Chedotal, I., Chander, J., Pakstis, D. L., Los-Arcos, I., Slavin, M., Montagna, M. T., Caggiano, G., Mares, M., Trauth, J., Aurbach, U., Vehreschild, M. J. G. T., Vehreschild, J. J., Duarte, R. F., Herbrecht, R., Wisplinghoff, H., & Cornely, O. A.
- Venue
- Critical Reviews in Microbiology
- Publisher
- Informa UK Limited
- Published
- 2019-01-02
- Volume
- 45
- Issue
- 1
- Pages
- 1-21
- ISSN
- 1040-841X (ISSN-L)
- 1549-7828
- OpenAlex
- W2910164778
- Cited by
- 159
- References
- 4
- FWCI
- 11.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®. https://app.cochat.ai/papers/10.1080/1040841x.2018.1514366
- The paper
- Seidel, D., Meißner, A., Lackner, M., Piepenbrock, E., Salmanton-García, J., Stecher, M., Mellinghoff, S., Hamprecht, A., Durán Graeff, L., Köhler, P., Cheng, M. P., Denis, J., Chedotal, I., Chander, J., Pakstis, D. L., Los-Arcos, I., Slavin, M., Montagna, M. T., Caggiano, G., . . . Cornely, O. A. (2019). Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®. Critical Reviews in Microbiology. https://doi.org/10.1080/1040841x.2018.1514366
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.